Seth Forman

Publications by Year

Research Areas

Dermatology and Skin Diseases, Allergic Rhinitis and Sensitization, Asthma and respiratory diseases, Food Allergy and Anaphylaxis Research, Autoimmune Bullous Skin Diseases

Most-Cited Works

• → Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa(2016)753 cited
• → Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity(2023)595 cited
• → Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial(2020)460 cited
• → Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis(2021)427 cited
• → Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study(2018)306 cited
• → Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies(2021)281 cited
• → Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study(2019)249 cited
• → Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis(2019)235 cited
• → A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial(2019)168 cited
• → Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa(2021)160 cited